Physician profile
Mark Scheidler
NPI 1609878214
$11,948.59
in general payments reported to CMS, 2019-2025
44 companies · $2,468 in 2025
The $2,468 reported for 2025 was more than what 83% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,370 · 2020: $575 · 2021: $1,725 · 2022: $1,823 · 2023: $1,862 · 2024: $2,127 · 2025: $2,468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,383 · Education: $73.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,382.93 |
| Education | $73.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,309.96 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,761.36 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Janssen Biotech, INC. | $952.64 | 2019-2025 | Stelara, Tremfya, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $760.19 | 2019-2025 | Entyvio, Eohilia |
| Celgene Corporation | $615.07 | 2021-2024 | Zeposia |
| Pfizer INC. | $487.83 | 2019-2025 | |
| Gilead Sciences, INC. | $392.22 | 2019-2023 | |
| Genzyme Corporation | $306.34 | 2022-2025 | |
| Nestle Healthcare Nutrition INC. | $265.28 | 2021-2023 | |
| Ardelyx, INC. | $210.74 | 2023-2025 | Ibsrela |
| Allergan, INC. | $163.87 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $157.29 | 2023-2025 | Dupixent |
| Ironwood Pharmaceuticals, INC | $151.40 | 2020-2024 | Linzess |
| Ipsen Biopharmaceuticals, INC | $139.40 | 2024-2025 | Iqirvo, Bylvay |
| Aimmune Therapeutics, INC. | $111.07 | 2024 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Scheidler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.